Dentsply Sirona Inc. (XRAY) climbed 1.0% in premarket trading Wednesday, after the dental products maker provided an upbeat full-year revenue outlook. The company, which is presenting at the J.P. Morgan Healthcare Conference Wednesday morning, said it expects 2022 sales to be "above the high end" of its previous guidance of $3.85 billion to $3.88 billion. That would put revenue above the FactSet consensus of $3.87 billion. The company said it expects earnings per share excluding nonrecurring items to be within previous guidance of $1.90 to $2.00, which surrounds the FactSet consensus of $1.96. The company is projected to report fourth-quarter results in late February. The stock has rallied 18.3% over the past three months through Tuesday, while the S&P 500 has gained 9.2%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.